Intellectual Property Law Center (MIPLC), 2010.

ج. اسناد سازمان‌ها
61. “Access to essential medicines”, EB134/31, WHO, 14 January 2014.
http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_31-en.pdf, last visited: 05/10/2015.
62. “Access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health”, Human Rights Council, A/HRC/23/L.10/Rev.1, United Nations, 11 June 2013.
http://ap.ohchr.org/documents/E/HRC/d_res_dec/A_HRC_23_L10_Rev1.doc, last visited: 05/11/2015.
63. “Amendment of the TRIPS Agreement”, Wt/L/641, WTO, 8 December 2005.
https://www.wto.org/english/tratop_e/trips_e/ta_docs_e/3_wtl641_e.pdf, last visited: 05/07/2015.
64. “Antitrust: Commission enforcement action in pharmaceutical sector following sector inquiry”, European Commission, 2012. & “Antitrust: shortcomings in pharmaceutical sector require further action”, IP/09/1098, Brussels, 2009.
http://europa.eu/rapid/pressReleasesAction.do?reference=MEMO/12/593&format=HTML&aged=0&language=EN&guiLanguage=en, last visited: 10/27/2014.
65. “Bangui Agreement”. Annex I.
http://www.wipo.int/wipolex/en/other_treaties/text.jsp?file_id=181150#P891_63028., last visited: 10/28/2013.
66. “Brazil – Measures Affecting Patent Protection”, Request for Consultations by the United States, WTO, WT/DS199/1, G/L/385, IP/D/23, 8 June 2000.
https://docs.wto.org/dol2fe/Pages/FE_Search/DDFDocuments/35212/Q/G/L/385.pdf, last visited: 10/08/2014.
67. “Brazil – Measures Affecting Patent Protection – Notification of Mutually Agreed Solution”, WTO, WT/DS199/4, G/L/454, IP/D/23/Add.1 19 July 2001.
https://docs.wto.org/dol2fe/Pages/FE_Search/FE_S_S009DP.aspx?language=E&CatalogueIdList=34253&CurrentCatalogueIdIndex=0&FullTextSearch=, last visited: 10/09/2014.
68. “Competition Issues in the Distribution of Pharmaceuticals”. Global Forum on Competition, Contribution from the European Union, Organisation for Economic Co-operation and Development, DAF/COMP/GF/WD(2014)32, 2014.
http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=DAF/COMP/GF/WD(2014)32&docLanguage=En, last visited: 10/21/2014.
69. “Competition Issues in the Distribution of Pharmaceuticals”. Global Forum on Competition, Contribution from the European Union, Organisation for Economic Co-operation and Development, DAF/COMP/GF/WD(2014)11, 2014.
70. Constitution of the World Health Organization. Who, 1946.
http://www.who.int/governance/eb/who_constitution_en.pdf, last visited: 09/22/2014.
71. Council Regulation (EC) No. 1383/2003. European Union (EU), 22 July 2003.
http://www.wipo.int/clea/en/details.jsp?id=1455, last visited: 11/24/2014.
72. Declaration of Alma-Ata, international conference on primary heath care, Alma-Ata, USSR, 6-12, September 1978.
http.//www.who.int/publications/almaata-declaration-en.pdf, last visited: 06/07/2014.
73. Declaration of the rights of the child. UN, 1959.
http://www.humanium.org/en/childrens-rights-history/references-on-child-rights/declaration-rights-child/, last visited: 03/06/2015.
74. Declaration on the TRIPS Agreement and Public Health, WT/MIN(01)/DEC/2, 20 Nov. 2001, WTO.
https://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm. , last visited: 09/29/2014.
75. European patent convention (EPC). EPO, 1973.
https://www.epo.org/law-practice/legal-texts/archive/epc-1973.html.
76. “European Union and a Member State – Seizure of Generic Drugs in Transit”. Request for Consultations by India, Wt/Ds408/1g/L/921 Ip/D/28, World Trade Organization, 19 May 2010.
http://infojustice.org/download/acta-a2m/government/India%20Request%20for%20Consultation%20(05.19.10).pdf, last visited: 11/24/2014.
77. “Executive Summary of the Discussion on Competition and Generic Pharmaceuticals”. Annex To The Summary Record Of The 121st Meeting Of The Competition Committee Held On 18-19 June 2014, Daf/Comp/M(2014)2/Ann6/Final, Organisation for Economic Co-operation and Development, 10-Feb 2015.
http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=DAF/COMP/M(2014)2/ANN6/FINAL&doclanguage=en, last visited: 10/28/2014.
78. “Extension of the Transition Period under Article 66.1 for Least Developed Country Members”. Council for Trade-Related Aspects of Intellectual Property Rights, IP/C/64, WTO, 12 June 2013.
http://www.ipi.gov.mz/IMG/pdf/Decisao_do_Conselho_do_TRIPS_da_OMC_sobre_a_extensao_do_prazo_de_transicao_para_os_PMA.pdf, last visited: 09/30/2014.
79. “Extension of the Transition Period under Article 66.1 for Least-Developed Country Members”, IP/C/40, WTO, 30 November 2005.
http://www.wto.int/english/tratop_e/trips_e/ta_docs_e/7_1_ipc40_e.pdf, last visited: 03/28/2015.
80. “Extension of the Transition Period under Article 66.1 of the TRIPS Agreement for Least-Developed Country Members for Certain Obligations with Respect to Pharmaceutical Products”. IP/C/25, WTO, 1 July 2002.
https://www.wto.org/english/tratop_e/trips_e/art66_1_e.htm, last visited: 03/20/2015.
81. “Feasibility Study on the Disclosure of International Nonproprietary Names (Inn) In Patent Applications and/or Patents”, Scp/21/9, WIPO, September 23, 2014.
http://www.wipo.int/edocs/mdocs/scp/en/scp_21/scp_21_9.pdf, last visited: 05/06/2015.
82. “General Comment No. 14: The Right to the Highest Attainable Standard of Health”. E/C.12/2000/4, UN Committee on Economic, Social and Cultural Rights, 11 August 2000.
http://www.nesri.org/resources/general-comment-no-14-the-right-to-the-highest-attainable-standard-of-health, last visited: 09/23/2014
83. “Generic Pharmaceuticals”. Daf/Comp(2009)39, Organisation For Economic Co-Operation And Development, 2010.
http://www.oecd.org/competition/abuse/46138891.pdf, last visited: 10/25/2014.
84. “Generic Pharmaceuticals”. Note By Chinese Taipei, Daf/Comp/Wd(2014)56, Organisation For Economic Co-Operation And Development, 2014.
http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=DAF/COMP/WD(2014)56&docLanguage=En, last visited: 10/30/2014.
85. “Global Report: UNAIDS Report on the Global AIDS Epidemic”. UNAIDS, 2012.
http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf, last visited: 03/09/2015.
86. “Global Status Report on Noncommunicable Diseases”. WHO, 2010.
http://whqlibdoc.who.int/publications/2011/9789240686458_eng.pdf, last visited: 03/11/2015.
87. “Globalization, TRIPS and access to pharmaceuticals”. WHO Policy Perspectives on Medicines, No. 3, WHO, Geneva, March 2001.
http://apps.who.int/medicinedocs/pdf/s2240e/s2240e.pdf, last visited: 09/27/2014., last visited: 03/08/2015.
88. “Health intervention and technology assessment in support of universal health coverage”. EB134/30, WHO, 14 January 2014.
http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_30-en.pdf.
89. “Implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health”. Decision of the General Council of 30 August 2003, Doc.WT/L/540 , WTO, 1 September 2003.
https://www.wto.org/english/tratop_e/trips_e/implem_para6_e.htm, last visited: 09/30/2014.
90. “Indian Supreme Court delivers verdict in Novarits case”. MSF, 1 April 2013.
http://www.msf.org/article/indian-supreme-court-delivers-verdict-novartis-case, last visited: 2015/12/01.
91. International Covenant on Economic, Social and Cultural Rights. Office of the United Nations High Commissioner for Human Rights, 1966.
http://www.ohchr.org/EN/ProfessionalInterest/Pages/CESCR.aspx, last visited: 09/26/2014.
92. “Issue Brief on TRIPS transition period extensions for least-developed countries”. UNDP, UNAIDS, 2013.
http://www.unaids.org/sites/default/files/media_asset/JC2474_TRIPS-transition-period extensions_en_0.pdf, las
t visited: 10/19/2014.
93. “National Intellectual Property Systems, Innovation and Economic Development”. OECD, 2014.
http://www.oecd.org/sti/inno/ip-innovation-development-main-findings.pdf, last visited: 09/26/2014.
94. Paris Convention for the protection of industrial property. 1883, WIPO.
95. ““Patents and Health: Proposal by the Delegation of the United States Of America”. SCP/17/11, WIPO, December 7, 2011.
http://www.wipo.int/edocs/mdocs/scp/en/scp_17/scp_17_11.pdf
96. “Patent Related Flexibilities in the Multilateral Legal Framework and Their Legislative Implementation at the National and Regional Levels”. CDIP; WIPO, CDIP/5/4, Geneva, 2010.
http://www.wipo.int/edocs/mdocs/mdocs/en/cdip_5/cdip_5_4-main1.pdf, last visited: 10/10/2014.
97. “Patent Related Flexibilities in the Multilateral Legal Framework and their Legislative Implementation at the National and Regional Levels”. WIPO, CDIP/5/4 REV, Annex II, Aug 18, 2010.
http://www.wipo.int/meetings/en/doc_details.jsp?doc_id=142068, last visited: 10/11/2014.
98. “Political Declaration on HIV and AIDS: Intensifying Our Efforts to Eliminate HIV and AIDS”. General Assembly of United Nations, A/RES/65/277, New York, 2011.
http://www.unaids.org/sites/default/files/sub_landing/files/20110610_UN_A-RES-65-277_en.pdf, last visited: 09/26/2014.
99. “Progress report 2011: Global HIV/AIDS response”. UNAIDS; WHO; UNICEF, 2011.
http://www.who. int/hiv/pub/progress_report2011/en/index.html/, last visited: 10/18/2014.
100. “Promotion and Protection of All Human Rights, Civil, Political, Economic, Social and Cultural Rights, Including the Right to Development”. United Nations, A/HRC/11/12, 31 March 2009.
http://www2.ohchr.org/english/bodies/hrcouncil/docs/11session/A.HRC.11.12_en.pdf, last visited: 03/22/2015.
101. “Proposal Submitted By the Delegation of South Africa On Behalf Of the African Group and the Development Agenda Group”. SCP/16/7, WIPO, 2011.
http://www.wipo.int/edocs/mdocs/scp/en/scp_16/scp_16_7.pdf, last visited: 02/19/2015.
102. “Regional issue brief: intellectual property rights and access to medicines”. Global commission on HIV and law; UNDP, South Africa,

مطلب مرتبط :   پایان نامه رایگان درموردحق ثبت اختراع، کشورهای درحال توسعه، سازمان تجارت جهانی
دسته بندی : پایان نامه ها

دیدگاهتان را بنویسید